Life Sciences Tools & Services Companies By De

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Debt To Equity
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Debt To EquityEfficiencyMarket RiskExp Return
1BIO-B Bio Rad Laboratories
13.9
(0.24)
 4.12 
(0.98)
2WAT Waters
4.0
(0.01)
 1.82 
(0.02)
3SHC Sotera Health Co
2.89
(0.10)
 2.20 
(0.21)
4IQV IQVIA Holdings
2.37
(0.10)
 1.60 
(0.16)
5PACB Pacific Biosciences of
1.51
(0.08)
 6.11 
(0.52)
6AVTR Avantor
1.46
(0.15)
 2.76 
(0.42)
7CRL Charles River Laboratories
1.27
(0.10)
 2.35 
(0.24)
8BRKR Bruker
1.2
(0.17)
 2.57 
(0.44)
9CSBR Champions Oncology
1.03
 0.08 
 5.48 
 0.42 
10MEDP Medpace Holdings
0.85
(0.05)
 2.00 
(0.11)
11HBIO Harvard Bioscience
0.73
(0.43)
 4.42 
(1.91)
12QGEN Qiagen NV
0.69
(0.13)
 1.51 
(0.20)
13MRVI Maravai Lifesciences Holdings
0.69
(0.22)
 5.63 
(1.24)
14TMO Thermo Fisher Scientific
0.67
(0.02)
 1.55 
(0.03)
15ICLR ICON PLC
0.64
(0.13)
 2.07 
(0.27)
16NOTV Inotiv Inc
0.6
(0.14)
 7.09 
(1.00)
17MLAB Mesa Laboratories
0.57
(0.04)
 2.85 
(0.12)
18A Agilent Technologies
0.52
(0.12)
 1.62 
(0.19)
19ILMN Illumina
0.38
(0.28)
 2.73 
(0.76)
20LAB Standard Biotools
0.38
(0.10)
 5.82 
(0.60)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company. High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY